Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?

Leuk Lymphoma. 2011 Apr;52(4):558-9. doi: 10.3109/10428194.2010.547643. Epub 2011 Feb 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Receptors, Fc / therapeutic use
  • Receptors, Thrombopoietin / antagonists & inhibitors
  • Recombinant Fusion Proteins / therapeutic use
  • Thrombopoietin / therapeutic use*

Substances

  • Antineoplastic Agents
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim